CIBC Private Wealth Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32M | Buy |
2,450,400
+210,400
| +9% | +$199K | ﹤0.01% | 529 |
|
|
2025
Q1 | $1.12M | Buy |
+2,240,000
| New | +$1.12M | ﹤0.01% | 631 |
|
|
2024
Q4 | – | Sell |
-50,010
| Closed | -$78.5K | – | 3099 |
|
|
2024
Q3 | $78.5K | Buy |
50,010
+50,000
| +500,000% | +$78.5K | ﹤0.01% | 1598 |
|
|
2024
Q2 | $16 | Hold |
10
| – | – | ﹤0.01% | 3116 |
|
|
2024
Q1 | $23 | Sell |
10
-150,090
| -100% | -$345K | ﹤0.01% | 3037 |
|
|
2023
Q4 | $230K | Buy |
+150,100
| New | +$230K | ﹤0.01% | 1022 |
|
|
2023
Q3 | – | Sell |
-30,000
| Closed | -$68.7K | – | 1114 |
|
|
2023
Q2 | $68.7K | Hold |
30,000
| – | – | ﹤0.01% | 857 |
|
|
2023
Q1 | $72.9K | Hold |
30,000
| – | – | ﹤0.01% | 859 |
|
|
2022
Q4 | $57 | Hold |
30,000
| – | – | ﹤0.01% | 837 |
|
|
2022
Q3 | $72K | Buy |
+30,000
| New | +$72K | ﹤0.01% | 882 |
|